Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients

American Journal of Kidney Diseases

Volumn 40, Issue 6, 2002, Pages 1195-1201

  Huang, Jenq Wen ^a   Yen, Chung Jen ^a   Pai, Mei Fen ^a   Wu, Kwan Dun ^a   Tsai, Tun Jun ^a   Hsieh, Bor Shen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Folic acid; Hemodialysis (HD); Homocysteine; Transaminase; Vitamin B12

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYANOCOBALAMIN; FOLIC ACID; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; HOMOCYSTEINE; METHIONINE; PYRIDOXAL 5 PHOSPHATE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; FOLIC ACID BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; TRANSAMINATION; VITAMIN BLOOD LEVEL;

EID: 0036896553     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.36948b     Document Type: Article

References (28)

1. Moustapha A, Gupta A, Robinson K, et al: Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis patients. Kidney Int 55:1470-1475, 1999
2. Tamura T, Bergman SM, Morgan SL: Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 32:475-481, 1998
3. 12, and serum and erythrocyte folate in peritoneal and hemodialysis patients. Perit Dial Int 20:169-173, 2000
4. Oishi K, Nagake Y, Yamasaki H, et al: The significance of serum homocysteine levels in diabetic patients on hemodialysis. Nephrol Dial Transplant 15:851-855, 2000
5. Robinson K, Gupta A, Dennis V, et al: Hyperhomocysteinemia confers an independent increased risk factor of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentration. Circulation 94:2743-2748, 1996
6. Shemin D, Lapane KL, Bausserman L, et al: Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. J Am Soc Nephrol 10:1095-1099, 1999
7. Bostom AG, Shemin D, Lapane KL, et al: Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 114:93-103, 1995
8. Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW: Hyperhomocysteinemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am J Kidney Dis 34:669-677, 1999
9. Balgent C, Burbury K, Wheeler D: Premature cardiovascular disease in chronic renal failure. Lancet 356:147-152, 2000
10. Tamura T, Johnston KE, Bergman SM: Homocysteine and folate concentrations in blood from patients with hemodialysis. J Am Soc Nephrol 7:2414-2418, 1996
11. House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC: Randomized trial of high-flux vs. low-flux hemodialysis: Effects on homocysteine and lipids. Nephrol Dial Transplant 15:1029-1034, 2000
12. Henning BF, Riezler R, Tepel M, et al: Evidence of altered homocysteine metabolism in chronic renal failure. Nephron 83:314-322, 1999
13. Van Guldener C, Kulik W, Berger R et al: Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 56:1064-1071, 1999
14. Scislowski PWD, Pickard K: Methionine transamination - Metabolic function and subcellular compartmentation. Mol Cell Biochem 129:39-45, 1993
15. Scislowski PWD, Pickard K: The regulation of transaminative flux of methionine in rat liver mitochondria. Arch Biochem Biophysics 314:412-416, 1994
16. Cooper AJL: Methionine transamination in vivo. Biochem J 262:689-691, 1989 (letter)
17. Tangerman A, Wilcken B, Levy HL, Boers GHJ, Mudd SH: Methionine transamination in patients with homocysteinuria due to cystathionine beta-synthase deficiency. Metabolism 49:1071-1077, 2000
18. Bates CJ, Pentieva KD, Matthews N, Macdonald A: A simple, sensitive and reproducible assay for pyridoxal 5′phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 280:101-111, 1999
19. Depner TA: Approach to hemodialysis kinetic modeling, in Henrich WL (ed): Principle and Practice of Dialysis (Ed. 2). Baltimore, MD, Williams and Wilkins, 1999, pp 79-98
20. Van Guldener C, Donker AJM, Jakobs C, Teerlink T, de Meer K, Stehouwer CDA: No net renal extraction of homocysteine in fasting humans. Kidney Int 54:166-169, 1998
21. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J: Net uptake of plasma homocysteine by the kidney in vivo. Atherosclerosis 116:59-62, 1995
22. Wollesen F, Brattsrom L, Refsum H, Ueland PM, Berglund L, Berne C: Plasma total Hcy and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55:1028-1035, 1999
23. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H: The effect of glomerular filtration rate on plasma total Hcy concentration. Scand J Clin Lab Invest 56:41-46, 1996
24. Perna AF, Ingrosso D, de Santo NG, Galletti P, Zappia V: Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 47:247-253, 1995
25. Perna AF, Ingrossso D, Zapppia V, Galletti P, Capasso G, de Santo NG: Enzymatic methyl esterification of erythrocyte membrane protein is impaired in chronic renal failure. J Clin Invest 91:2497-2503, 1993
26. Loehrer FMT, Angst CP, Brunner FP, Haefeli WE, Fowler B: Evidence for S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: A cause for disturbed methylation reactions? Nephrol Dial Transplant 13:656-661, 1998
27. Suliman ME, Anderstam B, Lindholm B, Bergstrom J: Total, free, and protein-bound sulphur amino acids in uremic patients. Nephrol Dial Transplant 12:2332-2338, 1997
28. Bostom AG, Shemin D, Verhoef P, et al: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arterioscler Thromb Vasc Biol 17:2554-2558, 1997